Clinical Trial Update: Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Clinical trial update on long-term safety and efficacy of Lyrica under post-marketing commitment; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuropathic Pain | Status: COMPLETED | Results posted: 2019-05-03